Human Vaccine Industry Research Report 2024

Human Vaccine Industry Research Report 2024


A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.

Highlights

The global Human Vaccine market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2025 and 2030.
In China, Human Vaccine key players include CNBG, Kangtai, ChengDa Bio, etc. Global top three manufacturers hold a share about 65%.
East China is the largest market, with a share about 25%, followed by South China, and North China, both have a share about 40 percent.
In terms of product, Hepatitis B is the largest segment, with a share nearly 15%. And in terms of application, the largest application is Children, followed by Adults.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Vaccine.
The Human Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Vaccine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Indian Immunologicals
KANGH
Henan Grand Biopharma
ZhongKe Biopharm
Zhuoyi Biological

Product Type Insights

Global markets are presented by Human Vaccine type, along with growth forecasts through 2030. Estimates on sales and revenue are based on the price in the supply chain at which the Human Vaccine are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
Human Vaccine segment by Type

Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Rota vaccine

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the Human Vaccine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Human Vaccine market.
Human Vaccine segment by Application
Adults
Children

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2019-2030.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Human Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Human Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Human Vaccine industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Vaccine.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Human Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Human Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Human Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Human Vaccine Market Size (2019-2030) & (US$ Million)
2.2.2 Global Human Vaccine Sales (2019-2030)
2.2.3 Global Human Vaccine Market Average Price (2019-2030)
2.3 Human Vaccine by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Rota vaccine
2.4 Human Vaccine by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Adults
2.4.3 Children
3 Market Competitive Landscape by Manufacturers
3.1 Global Human Vaccine Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Human Vaccine Sales (M Doses) of Manufacturers (2019-2024)
3.3 Global Human Vaccine Revenue of Manufacturers (2019-2024)
3.4 Global Human Vaccine Average Price by Manufacturers (2019-2024)
3.5 Global Human Vaccine Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Human Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Human Vaccine, Product Type & Application
3.8 Global Manufacturers of Human Vaccine, Date of Enter into This Industry
3.9 Global Human Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 CNBG
4.1.1 CNBG Company Information
4.1.2 CNBG Business Overview
4.1.3 CNBG Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.4 CNBG Human Vaccine Product Portfolio
4.1.5 CNBG Recent Developments
4.2 Changsheng Life
4.2.1 Changsheng Life Company Information
4.2.2 Changsheng Life Business Overview
4.2.3 Changsheng Life Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Changsheng Life Human Vaccine Product Portfolio
4.2.5 Changsheng Life Recent Developments
4.3 Zhifei
4.3.1 Zhifei Company Information
4.3.2 Zhifei Business Overview
4.3.3 Zhifei Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Zhifei Human Vaccine Product Portfolio
4.3.5 Zhifei Recent Developments
4.4 ChengDa Bio
4.4.1 ChengDa Bio Company Information
4.4.2 ChengDa Bio Business Overview
4.4.3 ChengDa Bio Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.4 ChengDa Bio Human Vaccine Product Portfolio
4.4.5 ChengDa Bio Recent Developments
4.5 Kangtai
4.5.1 Kangtai Company Information
4.5.2 Kangtai Business Overview
4.5.3 Kangtai Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Kangtai Human Vaccine Product Portfolio
4.5.5 Kangtai Recent Developments
4.6 SINOVAC BIOTECH
4.6.1 SINOVAC BIOTECH Company Information
4.6.2 SINOVAC BIOTECH Business Overview
4.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.6.4 SINOVAC BIOTECH Human Vaccine Product Portfolio
4.6.5 SINOVAC BIOTECH Recent Developments
4.7 Hissen
4.7.1 Hissen Company Information
4.7.2 Hissen Business Overview
4.7.3 Hissen Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Hissen Human Vaccine Product Portfolio
4.7.5 Hissen Recent Developments
4.8 Walvax Biotechnology
4.8.1 Walvax Biotechnology Company Information
4.8.2 Walvax Biotechnology Business Overview
4.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Walvax Biotechnology Human Vaccine Product Portfolio
4.8.5 Walvax Biotechnology Recent Developments
4.9 GSK
4.9.1 GSK Company Information
4.9.2 GSK Business Overview
4.9.3 GSK Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.9.4 GSK Human Vaccine Product Portfolio
4.9.5 GSK Recent Developments
4.10 SANOFI
4.10.1 SANOFI Company Information
4.10.2 SANOFI Business Overview
4.10.3 SANOFI Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.10.4 SANOFI Human Vaccine Product Portfolio
4.10.5 SANOFI Recent Developments
6.11 Rong An
6.11.1 Rong An Company Information
6.11.2 Rong An Human Vaccine Business Overview
6.11.3 Rong An Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Rong An Human Vaccine Product Portfolio
6.11.5 Rong An Recent Developments
6.12 NuoCheng Bio
6.12.1 NuoCheng Bio Company Information
6.12.2 NuoCheng Bio Human Vaccine Business Overview
6.12.3 NuoCheng Bio Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 NuoCheng Bio Human Vaccine Product Portfolio
6.12.5 NuoCheng Bio Recent Developments
6.13 Hualan Bio
6.13.1 Hualan Bio Company Information
6.13.2 Hualan Bio Human Vaccine Business Overview
6.13.3 Hualan Bio Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hualan Bio Human Vaccine Product Portfolio
6.13.5 Hualan Bio Recent Developments
6.14 Tiantan biological
6.14.1 Tiantan biological Company Information
6.14.2 Tiantan biological Human Vaccine Business Overview
6.14.3 Tiantan biological Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Tiantan biological Human Vaccine Product Portfolio
6.14.5 Tiantan biological Recent Developments
6.15 Changchun Baike
6.15.1 Changchun Baike Company Information
6.15.2 Changchun Baike Human Vaccine Business Overview
6.15.3 Changchun Baike Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Changchun Baike Human Vaccine Product Portfolio
6.15.5 Changchun Baike Recent Developments
6.16 Adimmune
6.16.1 Adimmune Company Information
6.16.2 Adimmune Human Vaccine Business Overview
6.16.3 Adimmune Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Adimmune Human Vaccine Product Portfolio
6.16.5 Adimmune Recent Developments
6.17 Zhongyianke Biotech
6.17.1 Zhongyianke Biotech Company Information
6.17.2 Zhongyianke Biotech Human Vaccine Business Overview
6.17.3 Zhongyianke Biotech Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Zhongyianke Biotech Human Vaccine Product Portfolio
6.17.5 Zhongyianke Biotech Recent Developments
6.18 Bharat Biotech
6.18.1 Bharat Biotech Company Information
6.18.2 Bharat Biotech Human Vaccine Business Overview
6.18.3 Bharat Biotech Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Bharat Biotech Human Vaccine Product Portfolio
6.18.5 Bharat Biotech Recent Developments
6.19 Bavarian Nordic
6.19.1 Bavarian Nordic Company Information
6.19.2 Bavarian Nordic Human Vaccine Business Overview
6.19.3 Bavarian Nordic Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Bavarian Nordic Human Vaccine Product Portfolio
6.19.5 Bavarian Nordic Recent Developments
6.20 Sanofi-Pasteur
6.20.1 Sanofi-Pasteur Company Information
6.20.2 Sanofi-Pasteur Human Vaccine Business Overview
6.20.3 Sanofi-Pasteur Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Sanofi-Pasteur Human Vaccine Product Portfolio
6.20.5 Sanofi-Pasteur Recent Developments
6.21 Indian Immunologicals
6.21.1 Indian Immunologicals Company Information
6.21.2 Indian Immunologicals Human Vaccine Business Overview
6.21.3 Indian Immunologicals Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Indian Immunologicals Human Vaccine Product Portfolio
6.21.5 Indian Immunologicals Recent Developments
6.22 KANGH
6.22.1 KANGH Company Information
6.22.2 KANGH Human Vaccine Business Overview
6.22.3 KANGH Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.22.4 KANGH Human Vaccine Product Portfolio
6.22.5 KANGH Recent Developments
6.23 Henan Grand Biopharma
6.23.1 Henan Grand Biopharma Company Information
6.23.2 Henan Grand Biopharma Human Vaccine Business Overview
6.23.3 Henan Grand Biopharma Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Henan Grand Biopharma Human Vaccine Product Portfolio
6.23.5 Henan Grand Biopharma Recent Developments
6.24 ZhongKe Biopharm
6.24.1 ZhongKe Biopharm Company Information
6.24.2 ZhongKe Biopharm Human Vaccine Business Overview
6.24.3 ZhongKe Biopharm Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.24.4 ZhongKe Biopharm Human Vaccine Product Portfolio
6.24.5 ZhongKe Biopharm Recent Developments
6.25 Zhuoyi Biological
6.25.1 Zhuoyi Biological Company Information
6.25.2 Zhuoyi Biological Human Vaccine Business Overview
6.25.3 Zhuoyi Biological Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Zhuoyi Biological Human Vaccine Product Portfolio
6.25.5 Zhuoyi Biological Recent Developments
5 Global Human Vaccine Market Scenario by Region
5.1 Global Human Vaccine Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Human Vaccine Sales by Region: 2019-2030
5.2.1 Global Human Vaccine Sales by Region: 2019-2024
5.2.2 Global Human Vaccine Sales by Region: 2025-2030
5.3 Global Human Vaccine Revenue by Region: 2019-2030
5.3.1 Global Human Vaccine Revenue by Region: 2019-2024
5.3.2 Global Human Vaccine Revenue by Region: 2025-2030
5.4 North America Human Vaccine Market Facts & Figures by Country
5.4.1 North America Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Human Vaccine Sales by Country (2019-2030)
5.4.3 North America Human Vaccine Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Human Vaccine Market Facts & Figures by Country
5.5.1 Europe Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Human Vaccine Sales by Country (2019-2030)
5.5.3 Europe Human Vaccine Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Human Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Human Vaccine Sales by Country (2019-2030)
5.6.3 Asia Pacific Human Vaccine Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Human Vaccine Market Facts & Figures by Country
5.7.1 Latin America Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Human Vaccine Sales by Country (2019-2030)
5.7.3 Latin America Human Vaccine Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Human Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Human Vaccine Sales by Country (2019-2030)
5.8.3 Middle East and Africa Human Vaccine Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Human Vaccine Sales by Type (2019-2030)
6.1.1 Global Human Vaccine Sales by Type (2019-2030) & (M Doses)
6.1.2 Global Human Vaccine Sales Market Share by Type (2019-2030)
6.2 Global Human Vaccine Revenue by Type (2019-2030)
6.2.1 Global Human Vaccine Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Human Vaccine Revenue Market Share by Type (2019-2030)
6.3 Global Human Vaccine Price by Type (2019-2030)
7 Segment by Application
7.1 Global Human Vaccine Sales by Application (2019-2030)
7.1.1 Global Human Vaccine Sales by Application (2019-2030) & (M Doses)
7.1.2 Global Human Vaccine Sales Market Share by Application (2019-2030)
7.2 Global Human Vaccine Revenue by Application (2019-2030)
6.2.1 Global Human Vaccine Sales by Application (2019-2030) & (US$ Million)
6.2.2 Global Human Vaccine Revenue Market Share by Application (2019-2030)
7.3 Global Human Vaccine Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Human Vaccine Value Chain Analysis
8.1.1 Human Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Human Vaccine Production Mode & Process
8.2 Human Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Human Vaccine Distributors
8.2.3 Human Vaccine Customers
9 Global Human Vaccine Analyzing Market Dynamics
9.1 Human Vaccine Industry Trends
9.2 Human Vaccine Industry Drivers
9.3 Human Vaccine Industry Opportunities and Challenges
9.4 Human Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 4. Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 5. Global Human Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2019 Versus 2023)
Table 6. Global Human Vaccine Sales (M Doses) of Manufacturers (2019-2024)
Table 7. Global Human Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 8. Global Human Vaccine Revenue of Manufacturers (2019-2024)
Table 9. Global Human Vaccine Revenue Share by Manufacturers (2019-2024)
Table 10. Global Market Human Vaccine Average Price (USD/Dose) of Manufacturers (2019-2024)
Table 11. Global Human Vaccine Industry Ranking, 2022 VS 2023 VS 2024
Table 12. Global Manufacturers of Human Vaccine, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. CNBG Company Information
Table 17. CNBG Business Overview
Table 18. CNBG Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 19. CNBG Human Vaccine Product Portfolio
Table 20. CNBG Recent Developments
Table 21. Changsheng Life Company Information
Table 22. Changsheng Life Business Overview
Table 23. Changsheng Life Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 24. Changsheng Life Human Vaccine Product Portfolio
Table 25. Changsheng Life Recent Developments
Table 26. Zhifei Company Information
Table 27. Zhifei Business Overview
Table 28. Zhifei Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 29. Zhifei Human Vaccine Product Portfolio
Table 30. Zhifei Recent Developments
Table 31. ChengDa Bio Company Information
Table 32. ChengDa Bio Business Overview
Table 33. ChengDa Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 34. ChengDa Bio Human Vaccine Product Portfolio
Table 35. ChengDa Bio Recent Developments
Table 36. Kangtai Company Information
Table 37. Kangtai Business Overview
Table 38. Kangtai Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 39. Kangtai Human Vaccine Product Portfolio
Table 40. Kangtai Recent Developments
Table 41. SINOVAC BIOTECH Company Information
Table 42. SINOVAC BIOTECH Business Overview
Table 43. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 44. SINOVAC BIOTECH Human Vaccine Product Portfolio
Table 45. SINOVAC BIOTECH Recent Developments
Table 46. Hissen Company Information
Table 47. Hissen Business Overview
Table 48. Hissen Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 49. Hissen Human Vaccine Product Portfolio
Table 50. Hissen Recent Developments
Table 51. Walvax Biotechnology Company Information
Table 52. Walvax Biotechnology Business Overview
Table 53. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 54. Walvax Biotechnology Human Vaccine Product Portfolio
Table 55. Walvax Biotechnology Recent Developments
Table 56. GSK Company Information
Table 57. GSK Business Overview
Table 58. GSK Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 59. GSK Human Vaccine Product Portfolio
Table 60. GSK Recent Developments
Table 61. SANOFI Company Information
Table 62. SANOFI Business Overview
Table 63. SANOFI Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 64. SANOFI Human Vaccine Product Portfolio
Table 65. SANOFI Recent Developments
Table 66. Rong An Company Information
Table 67. Rong An Business Overview
Table 68. Rong An Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 69. Rong An Human Vaccine Product Portfolio
Table 70. Rong An Recent Developments
Table 71. NuoCheng Bio Company Information
Table 72. NuoCheng Bio Business Overview
Table 73. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 74. NuoCheng Bio Human Vaccine Product Portfolio
Table 75. NuoCheng Bio Recent Developments
Table 76. Hualan Bio Company Information
Table 77. Hualan Bio Business Overview
Table 78. Hualan Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 79. Hualan Bio Human Vaccine Product Portfolio
Table 80. Hualan Bio Recent Developments
Table 81. Tiantan biological Company Information
Table 82. Tiantan biological Business Overview
Table 83. Tiantan biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 84. Tiantan biological Human Vaccine Product Portfolio
Table 85. Tiantan biological Recent Developments
Table 86. Changchun Baike Company Information
Table 87. Changchun Baike Business Overview
Table 88. Changchun Baike Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 89. Changchun Baike Human Vaccine Product Portfolio
Table 90. Changchun Baike Recent Developments
Table 91. Adimmune Company Information
Table 92. Adimmune Business Overview
Table 93. Adimmune Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 94. Adimmune Human Vaccine Product Portfolio
Table 95. Adimmune Recent Developments
Table 96. Zhongyianke Biotech Company Information
Table 97. Zhongyianke Biotech Business Overview
Table 98. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 99. Zhongyianke Biotech Human Vaccine Product Portfolio
Table 100. Zhongyianke Biotech Recent Developments
Table 101. Bharat Biotech Company Information
Table 102. Bharat Biotech Business Overview
Table 103. Bharat Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 104. Bharat Biotech Human Vaccine Product Portfolio
Table 105. Bharat Biotech Recent Developments
Table 106. Bavarian Nordic Company Information
Table 107. Bavarian Nordic Business Overview
Table 108. Bavarian Nordic Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 109. Bavarian Nordic Human Vaccine Product Portfolio
Table 110. Bavarian Nordic Recent Developments
Table 111. Sanofi-Pasteur Company Information
Table 112. Sanofi-Pasteur Business Overview
Table 113. Sanofi-Pasteur Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 114. Sanofi-Pasteur Human Vaccine Product Portfolio
Table 115. Sanofi-Pasteur Recent Developments
Table 116. Indian Immunologicals Company Information
Table 117. Indian Immunologicals Business Overview
Table 118. Indian Immunologicals Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 119. Indian Immunologicals Human Vaccine Product Portfolio
Table 120. Indian Immunologicals Recent Developments
Table 121. KANGH Company Information
Table 122. KANGH Business Overview
Table 123. KANGH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 124. KANGH Human Vaccine Product Portfolio
Table 125. KANGH Recent Developments
Table 126. Henan Grand Biopharma Company Information
Table 127. Henan Grand Biopharma Business Overview
Table 128. Henan Grand Biopharma Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 129. Henan Grand Biopharma Human Vaccine Product Portfolio
Table 130. Henan Grand Biopharma Recent Developments
Table 131. ZhongKe Biopharm Company Information
Table 132. ZhongKe Biopharm Business Overview
Table 133. ZhongKe Biopharm Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 134. ZhongKe Biopharm Human Vaccine Product Portfolio
Table 135. ZhongKe Biopharm Recent Developments
Table 136. Zhuoyi Biological Company Information
Table 137. Zhuoyi Biological Business Overview
Table 138. Zhuoyi Biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 139. Zhuoyi Biological Human Vaccine Product Portfolio
Table 140. Zhuoyi Biological Recent Developments
Table 141. Global Human Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 142. Global Human Vaccine Sales by Region (2019-2024) & (M Doses)
Table 143. Global Human Vaccine Sales Market Share by Region (2019-2024)
Table 144. Global Human Vaccine Sales by Region (2025-2030) & (M Doses)
Table 145. Global Human Vaccine Sales Market Share by Region (2025-2030)
Table 146. Global Human Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 147. Global Human Vaccine Revenue Market Share by Region (2019-2024)
Table 148. Global Human Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 149. Global Human Vaccine Revenue Market Share by Region (2025-2030)
Table 150. North America Human Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 151. North America Human Vaccine Sales by Country (2019-2024) & (M Doses)
Table 152. North America Human Vaccine Sales by Country (2025-2030) & (M Doses)
Table 153. North America Human Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 154. North America Human Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 155. Europe Human Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 156. Europe Human Vaccine Sales by Country (2019-2024) & (M Doses)
Table 157. Europe Human Vaccine Sales by Country (2025-2030) & (M Doses)
Table 158. Europe Human Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 159. Europe Human Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 160. Asia Pacific Human Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 161. Asia Pacific Human Vaccine Sales by Country (2019-2024) & (M Doses)
Table 162. Asia Pacific Human Vaccine Sales by Country (2025-2030) & (M Doses)
Table 163. Asia Pacific Human Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 164. Asia Pacific Human Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 165. Latin America Human Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 166. Latin America Human Vaccine Sales by Country (2019-2024) & (M Doses)
Table 167. Latin America Human Vaccine Sales by Country (2025-2030) & (M Doses)
Table 168. Latin America Human Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 169. Latin America Human Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 170. Middle East and Africa Human Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 171. Middle East and Africa Human Vaccine Sales by Country (2019-2024) & (M Doses)
Table 172. Middle East and Africa Human Vaccine Sales by Country (2025-2030) & (M Doses)
Table 173. Middle East and Africa Human Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 174. Middle East and Africa Human Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 175. Global Human Vaccine Sales by Type (2019-2024) & (M Doses)
Table 176. Global Human Vaccine Sales by Type (2025-2030) & (M Doses)
Table 177. Global Human Vaccine Sales Market Share by Type (2019-2024)
Table 178. Global Human Vaccine Sales Market Share by Type (2025-2030)
Table 179. Global Human Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 180. Global Human Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 181. Global Human Vaccine Revenue Market Share by Type (2019-2024)
Table 182. Global Human Vaccine Revenue Market Share by Type (2025-2030)
Table 183. Global Human Vaccine Price by Type (2019-2024) & (USD/Dose)
Table 184. Global Human Vaccine Price by Type (2025-2030) & (USD/Dose)
Table 185. Global Human Vaccine Sales by Application (2019-2024) & (M Doses)
Table 186. Global Human Vaccine Sales by Application (2025-2030) & (M Doses)
Table 187. Global Human Vaccine Sales Market Share by Application (2019-2024)
Table 188. Global Human Vaccine Sales Market Share by Application (2025-2030)
Table 189. Global Human Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 190. Global Human Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 191. Global Human Vaccine Revenue Market Share by Application (2019-2024)
Table 192. Global Human Vaccine Revenue Market Share by Application (2025-2030)
Table 193. Global Human Vaccine Price by Application (2019-2024) & (USD/Dose)
Table 194. Global Human Vaccine Price by Application (2025-2030) & (USD/Dose)
Table 195. Key Raw Materials
Table 196. Raw Materials Key Suppliers
Table 197. Human Vaccine Distributors List
Table 198. Human Vaccine Customers List
Table 199. Human Vaccine Industry Trends
Table 200. Human Vaccine Industry Drivers
Table 201. Human Vaccine Industry Restraints
Table 202. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Human VaccineProduct Picture
Figure 5. Global Human Vaccine Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 6. Global Human Vaccine Market Size (2019-2030) & (US$ Million)
Figure 7. Global Human Vaccine Sales (2019-2030) & (M Doses)
Figure 8. Global Human Vaccine Average Price (USD/Dose) & (2019-2030)
Figure 9. Varicella Product Picture
Figure 10. Influenza Product Picture
Figure 11. Polio Product Picture
Figure 12. Hepatitis A Product Picture
Figure 13. Rabies Product Picture
Figure 14. BCG Product Picture
Figure 15. Hepatitis B Product Picture
Figure 16. Pertussis, Diphtheria, Tetanus Product Picture
Figure 17. Pneumococcal Product Picture
Figure 18. Rota vaccine Product Picture
Figure 19. Adults Product Picture
Figure 20. Children Product Picture
Figure 21. Global Human Vaccine Revenue Share by Manufacturers in 2023
Figure 22. Global Manufacturers of Human Vaccine, Manufacturing Sites & Headquarters
Figure 23. Global Manufacturers of Human Vaccine, Date of Enter into This Industry
Figure 24. Global Top 5 and 10 Human Vaccine Players Market Share by Revenue in 2023
Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 26. Global Human Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 27. Global Human Vaccine Sales by Region in 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings